Getting ready for ICE/ENDO 2014

Countdown to ICE/ENDO 2014 in Chicago Begins

As president of The Endocrine Society it has been my honor to work with the Annual Meeting Steering Committee (AMSC), including the eight members of the Program Organizing Committee from the International Society of Endocrinology, to plan this exciting meeting. Under the excellent leadership of its chairs, Derek Leroith, Kevin Grove, Matthew Ringel, and our first clinicianin-practice chair, Carol Wysham, the AMSC has created a scientific program that showcases the most cutting-edge research and clinical practices and features international perspectives on the practice of endocrinology.

Attendees will fi nd much to choose from with more than 80 symposia, 70 Meet-the-Professor sessions, and numerous special clinical, basic, and educational sessions. The excellent scientific program and opportunities to meet attendees from around the world will make ICE/ENDO 2014 a meeting not to be missed.

A few highlights of this year’s meeting include:
• Diabetes Diagnosis & Management (DDM) The Friday before ENDO offi cially begins, the Society off ers this full-day program in recognition of the worldwide epidemic of diabetes. DDM provides an in-depth discussion of current practice challenges and a state-of-the-art update for all who treat diabetes.
• Early Career Forum Also on Friday, this fullday program ( formerly Endocrine Trainee Day) off ers opportunities for fellows and students to interact with their peers and be inspired by recognized leaders from our endocrine community.
• The oral sessions and the poster presentations are the heart of our annual meeting. Abstracts are due Jan. 29, 2014, so talk with your team to be ready for submission!
• Featured Poster Presentations Returning for the second year, presenters with the highestscoring poster abstracts will each have just three minutes to review three slides highlighting the significance of their research. These sessions will take place immediately before oral sessions, on the same day as the posters are presented.
• Endocrine Year In … These sessions will recap the most important advances of the year in the areas of type 1 diabetes, pituitary disease, reproduction, germ cells, and stem cells.
• Master Clinicians Sessions ICE/ENDO 2014 will feature two of these highly popular sessions, in which experienced clinical endocrinologists present their most challenging cases to endocrine experts. This year’s sessions cover lipid disorders and thyroid cancer. Come and enjoy these lively and informative exchanges.

The Expo is the hub of activity during the meeting and home to exhibits, posters, cafes, and places to lounge and network with your colleagues. Start each morning with a complimentary cup of coffee, and grab lunch at the Expo while you peruse the posters and exhibits.

Don’t forget to sign a team up for the fifth annual ENDO Trivia Cup Challenge, moderated by Brad Anawalt and Jon Levine. This event is entertaining and lighthearted, and will test your endocrine knowledge!

Chicago, my hometown, is a vibrant city and a world-class travel destination. I look forward to welcoming you here for an outstanding ICE/ENDO!

Please share your comments, questions, and ideas by writing to me via president@endo-society.org

Teresa K. Woodruff, PhD
President, The Endocrine Society

You may also like

  • Introducing the New President: Gary D. Hammer, MD, PhD

    The Endocrine Society is pleased to welcome its president for 2020–2021, Gary D. Hammer, MD, PhD, who took office at the Society’s virtual business meeting on April 6. As director of the Endocrine Oncology Program at the University of Michigan Rogel Cancer Center in Ann Arbor, his work on adrenal homeostasis focuses on progenitor cell…

  • Moving Forward: Strategic Plan is Right on Track

    The Society always invites your questions, comments, and solutions for improvement. This year especially, we proactively sought input into our Fourth Strategic Plan (SP4). We surveyed our membership, held focus group meetings (targeting international members and past leaders), and interviewed “lapsed” members and outside stakeholders (e.g. insurers, deans, pharma). The resulting input fed into the…